Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis
NCT01856803
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Leukemia, GVHD, ATG, Transplantation
Interventions
DRUG:
anti thymoglobulin
Sponsor
Peking University People's Hospital